APR 22, 2019 08:49 PM PDT

First Generic Naloxone Nasal Spray Approved To Treat Opioid Overdose

WRITTEN BY: Nouran Amin

The U.S. Food and Drug Administration has approved the first generic naloxone hydrochloride nasal spray. The spray is called Narcan and is a life-saving medication that can stop or reverse the effects of an opioid overdose.

According to the Centers for Disease Control and Prevention, about 400,000 people have died from an opioid overdose between 1999 to 2017. On average, 130 Americans die every day from opioid overdoses--a class of drugs that include prescription medications such as fentanyl, oxycodone, hydrocodone and morphine. Some opioids include illegal drugs such as heroin which contains fentanyl or derivatives of fentanyl.

“In the wake of the opioid crisis, a number of efforts are underway to make this emergency overdose reversal treatment more readily available and more accessible. In addition to this approval of the first generic naloxone nasal spray, moving forward we will prioritize our review of generic drug applications for naloxone. The FDA has also taken the unprecedented step of helping to assist manufacturers to pursue approval of an over-the-counter naloxone product and is exploring other ways to increase the availability of naloxone products intended for use in the community, including whether naloxone should be co-prescribed with all or some opioid prescriptions to reduce the risk of overdose death,” said Douglas Throckmorton, M.D., deputy center director for regulatory programs in the FDA’s Center for Drug Evaluation and Research.

“All together, these efforts have the potential to put a vital tool for combatting opioid overdose in the hands of those who need it most – friends and families of opioid users, as well as first responders and community-based organizations. We’re taking many steps to improve availability of naloxone products, and we’re committed to working with other federal, state and local officials as well as health care providers, patients and communities across the country to combat the staggering human and economic toll created by opioid abuse and addiction.”

Source: FDA

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Drug Increases Survival Rates for Heart Failure Patients
Scientists have demonstrated in preclinical studies that a drug called ‘Aliskiren’ works by inhibiting the activity of an enzyme involved in bl...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Tailor-made Drug for Girl with Rare Genetic Disease
Researchers have used personalized medicine to develop a tailor-made genetic treatment for a girl diagnosed with a rare genetic disease known as Batten dis...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Fecal Transplants Could Treat Irritable Bowel Syndrome
According to the American College of Gastroenterology, between 10 and 15% of Americans have Irritable Bowel Syndrome (IBS). Although treatments are current...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Possible New Drug Targets for Glioblastoma
Scientists at Karolinska Institutet in Sweden were able to pinpoint 10 tumor-specific potential drug targets for the fatal and incurable brain cancer, glio...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Psychedelic DMT Creates Vivid Waking Dream State in Brain
In a new study, scientists at Imperial College London investigated how powerful psychedelic dimethyltryptamine (DMT) alters the brain’s electrical ac...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Immunotherapy Drug Shows Promise for Treating Advanced Prostate Cancer
By the end of the year, an estimated 175,000 men in the United States will have been diagnosed with prostate cancer. Now, researchers from the UK have foun...
Loading Comments...